Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYOV | AMGN | VRTX | REGN | GILD |
| Company | Myovant Sciences Ltd | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 26.99 | 310.25 | 469.76 | 1,046.28 | 68.50 |
| High | 27.00 | 312.43 | 477.93 | 1,046.28 | 68.50 |
| Low | 26.98 | 307.64 | 467.41 | 1,046.28 | 68.50 |
| Last | 26.98 | 310.77 | 473.78 | 1,046.28 | 68.50 |
| Change | -0.01 | -0.24 | +2.53 | +1.62 | +0.10 |
| % Change | -0.04% | -0.08% | +0.54% | +0.16% | +0.15% |
| Volume | 2,256,000 | 1,542,800 | 852,500 | 461 | 734 |
| 20-Day Average Volume | 1,234,240 | 2,432,280 | 1,282,940 | 459,213 | 8,998,472 |
| Previous Close | 26.99 | 311.01 | 471.25 | 1,044.66 | 68.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.95 | 307.73 | 475.85 | 1,037.44 | 66.74 |
| 20-Day Raw Stochastic | 50.00% | 50.19% | 45.48% | 61.83% | 61.24% |
| 20-Day Relative Strength | 61.08% | 55.86% | 60.54% | 61.60% | 54.89% |
| Weighted Alpha | +96.20 | +36.35 | +41.72 | +47.67 | -10.23 |
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Last Month's Opinion | 96% Buy | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.11% since 03/02/23 | -2.67% since 06/25/24 | -0.01% since 06/25/24 | -2.14% since 06/26/24 | -1.17% since 06/26/24 |
| Low | 26.95 on 03/06/23 | 307.64 on 07/02/24 | 467.41 on 07/02/24 | 1,030.23 on 07/02/24 | 67.58 on 07/02/24 |
| High | 27.00 on 03/09/23 | 319.00 on 07/01/24 | 481.14 on 06/26/24 | 1,073.05 on 06/27/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | +0.30% since 02/09/23 | +1.61% since 05/31/24 | +4.05% since 05/31/24 | +5.74% since 06/03/24 | +7.99% since 06/03/24 |
| Low | 26.90 on 02/13/23 | 295.30 on 06/13/24 | 453.73 on 06/03/24 | 986.64 on 06/04/24 | 62.69 on 06/18/24 |
| High | 27.06 on 02/13/23 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | +0.71% since 12/09/22 | +12.51% since 04/02/24 | +15.72% since 04/02/24 | +10.02% since 04/03/24 | -3.37% since 04/03/24 |
| Low | 26.75 on 12/16/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 27.06 on 02/13/23 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | +36.13% since 09/09/22 | +4.50% since 01/02/24 | +15.30% since 01/02/24 | +14.03% since 01/03/24 | -17.94% since 01/03/24 |
| Low | 16.26 on 09/23/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 27.06 on 02/13/23 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,623,400 | 166,707,904 | 122,260,352 | 115,106,896 | 85,216,352 |
| Shares Outstanding, K | 97,235 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 230,970,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -205,980,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 100,230,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -57,630,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 2.17 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 01/26/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 01/25/23 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.69 | 31.29 | 28.48 | 17.03 |